PharmaCyte Biotech Inc (PMCB)

NASDAQ

$0.61

PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United States. The company is headquartered in Laguna Hills, California.

Website: https://pharmacyte.com

Sector:

Healthcare

Industry:

Biotechnology

Market Cap

$7.57M

P/B Ratio

0.18

Free Cash Flow Yield

-63.39%

Beta (5Y)

0.74

Price Chart

Adjust inflation

Log

Valuation

Market Cap$7.57M

Forward P/E7.02

P/S12904.41

P/B0.18

Profitability

EBITDA-$3.28M

EPS-$0.52

Financial Health

Free Cash Flow Yield-63.39%

Growth & Risk

FCF 5Y CAGR+9.64%

Beta (5Y)0.74

Sharpe Ratio-0.10